Triptans, drugs commonly prescribed for migraine relief, may be effective for the treatment of obesity. Daily triptan exposure led to reduced food intake and increased weight loss in mouse models.
A new study implicates serotonin 2c receptors with metabolic side effects caused by a common class of antipsychotic medications.
Researchers report a weight loss dampens the response to food cues in areas of the brain associated with emotion and attention.
